MML Investors Services’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,741
Closed -$2K 2404
2023
Q2
$2K Hold
10,741
﹤0.01% 2290
2023
Q1
$2K Hold
10,741
﹤0.01% 2019
2022
Q4
$6K Hold
10,741
﹤0.01% 2146
2022
Q3
$13K Hold
10,741
﹤0.01% 2068
2022
Q2
$7K Hold
10,741
﹤0.01% 2025
2022
Q1
$12K Hold
10,741
﹤0.01% 2051
2021
Q4
$24K Hold
10,741
﹤0.01% 2003
2021
Q3
$37K Hold
10,741
﹤0.01% 1935
2021
Q2
$32K Hold
10,741
﹤0.01% 1886
2021
Q1
$35K Hold
10,741
﹤0.01% 1788
2020
Q4
$23K Hold
10,741
﹤0.01% 1657
2020
Q3
$13K Hold
10,741
﹤0.01% 1569
2020
Q2
$10K Buy
+10,741
New +$10.2K ﹤0.01% 1507

Other funds holding INFI

MML Investors Services's INFI Position: Q3 2023 in Review

MML Investors Services sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 10,741 shares — an estimated $2K sold.

MML Investors Services first reported a position in INFI in Q2 2020 and held it in 13 quarters. The position peaked at $37K in Q3 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • MML Investors Services reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • MML Investors Services sold 10,741 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $2K.
  • MML Investors Services first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2020 and held it in 13 quarters.
  • MML Investors Services's Infinity Pharmaceuticals, Inc. position peaked at $37K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on MML Investors Services's 13F filing for Q3 2023, filed 14 Nov 2023.